JPMORGAN CHASE & CO - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422G907. A total of 5 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,5161,4000.00%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 202,300$1,808,5620.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
JPMORGAN CHASE & CO 1,400$12,5160.00%
SIMPLEX TRADING, LLC 69,700$6230.00%
JANE STREET GROUP, LLC 57,200$511,3680.00%
View complete list of TRAVERE THERAPEUTICS INC shareholders